Fish Oil Is Not Just Fish Oil: What Makes MaxSimil® Different

Fish oil labels can be deceptively simple. Two bottles may list similar amounts of EPA and DHA while delivering those fatty acids in different forms, with different testing standards and very different capsule sizes.

For someone who already eats fatty fish regularly, supplementation may not be necessary. For someone whose diet provides little marine omega-3, the practical questions are more specific: How much EPA and DHA does the product contain? Is the oil fresh and independently tested? Can the person tolerate it well enough to take it consistently? And does the formulation affect how much is absorbed?

EPA and DHA Are Not Just Numbers on a Label

EPA and DHA are long-chain marine fatty acids incorporated into cell membranes throughout the body. DHA is especially concentrated in the brain and retina. EPA participates in lipid metabolism and the production of signaling molecules involved in normal inflammatory regulation.

The body can make limited amounts of EPA and DHA from the alpha-linolenic acid found in plant foods, but conversion is modest. Salmon, sardines, anchovies, herring, trout and other fatty fish provide EPA and DHA directly. A supplement can provide a measured amount when those foods are eaten infrequently.

Eating seafood remains the preferred foundation. The American Heart Association recommends one to two servings of seafood each week as part of a heart-healthy dietary pattern. The evidence surrounding supplements is more selective. Omega-3 supplements can lower triglycerides, but ordinary over-the-counter fish oil has not consistently prevented cardiovascular events in otherwise healthy adults.

Prescription omega-3 therapy is a separate subject. High-dose prescription products are standardized for specific clinical uses and should not be treated as interchangeable with dietary supplements.

Why the Form of Fish Oil Can Affect Absorption

Fat digestion is a multistep process. Before many dietary fats can be absorbed, pancreatic enzymes and bile help break them into smaller components that can mix with the fluid environment of the intestine.

Conventional fish oils commonly provide omega-3 fatty acids in triglyceride or ethyl ester forms. MaxSimil® uses an enzymatic process to produce a monoglyceride-rich oil. Because monoglycerides are already products of normal fat digestion, they require less processing before intestinal absorption.

A randomized, double-blind crossover study compared equal EPA and DHA doses delivered as monoglycerides, triglycerides and ethyl esters. The monoglyceride-rich MaxSimil® formulation produced substantially greater EPA and DHA exposure in the blood after a low-fat meal.

The study supports the formulation’s enhanced-absorption claim. It does not establish that MaxSimil® provides three times the clinical benefit or that a lower labeled dose will always produce the same long-term result as a larger dose of another fish oil. The trial measured absorption over hours, not disease outcomes over years.

Absorption and Clinical Benefit Are Different Questions

A fish oil has to be absorbed before its fatty acids can be used. Better absorption is therefore a legitimate formulation advantage. It does not settle the larger medical questions surrounding omega-3 supplementation.

Large cardiovascular trials have produced mixed findings. EPA and DHA reliably lower triglycerides at appropriate doses, but trials of general fish oil supplementation have not shown uniform reductions in heart attack, stroke or cardiovascular death. Results vary with the population studied, dose, formulation, baseline seafood intake and medical risk.

The cardiovascular benefits reported with prescription icosapent ethyl cannot be assigned to every EPA- and DHA-containing supplement. Conversely, null results from one formulation do not mean that omega-3 status is irrelevant to nutrition or that all supplements are identical.

The National Institutes of Health provides a detailed review of the evidence in its Omega-3 Fatty Acids Health Professional Fact Sheet. Our discussion of the dose-dependent triglyceride evidence is available in Omega-3 and Triglycerides: What the Evidence Shows.

What RetzlerRx® Pure Omega Adds

RetzlerRx® Pure Omega formulas use MaxSimil® monoglyceride technology in an enteric-coated softgel. The coating delays release until the capsule has moved beyond the stomach, which may reduce fishy aftertaste and make daily supplementation easier to tolerate.*

The products are identified as IFOS® 5-Star certified. IFOS testing evaluates whether the measured EPA and DHA agree with the label and examines contaminants, oxidation and freshness. These are important quality questions for any marine oil because a large number on the front label says little about oxidation or manufacturing quality.

The current RetzlerRx® options include:

• Pure Omega 650 EC: Each enteric-coated softgel provides 300 mg of EPA and 130 mg of DHA, for 430 mg of combined EPA and DHA.*
• Pure Omega 1300 EC, 60 count: A higher-concentration MaxSimil® option in a 60-count bottle.*
• Pure Omega 1300 EC, 120 count: The same higher-concentration format in a larger bottle for ongoing use.*

The number in a product name refers to the fish oil concentrate, not necessarily the combined amount of EPA and DHA. The Supplement Facts panel remains the most useful place to compare products.

Who Might Consider an Omega-3 Supplement?

Supplementation may be reasonable for adults who rarely eat fatty fish, have a low measured Omega-3 Index or have a nutritional or clinical reason to increase EPA and DHA intake.*

An Omega-3 Index measures EPA and DHA within red blood cell membranes and reflects intake over approximately the previous three to four months. It can be more informative than assuming that everyone needs the same dose.

Triglyceride treatment requires additional care. Clinically meaningful triglyceride reduction generally uses more EPA and DHA than a foundational nutritional serving provides. Very high triglycerides may require prescription treatment and medical supervision. A dietary supplement should not be substituted for prescription omega-3 therapy, a statin or another prescribed cardiovascular medication.

At HormoneSynergy®, omega-3 use may be considered alongside seafood intake, triglycerides, ApoB, insulin resistance, visceral fat, cardiovascular risk, inflammatory patterns and brain-health goals. The capsule should have a defined purpose within the person’s larger health plan.

Safety and Tolerance

Fish oil is generally well tolerated, although reflux, nausea, loose stools and fishy aftertaste can occur. The enteric coating used in Pure Omega is intended to improve digestive tolerance.*

People taking anticoagulant or antiplatelet medication, those with a bleeding disorder, individuals preparing for surgery and anyone with atrial fibrillation or another rhythm disorder should discuss supplementation with a healthcare professional. High-dose omega-3 therapy has been associated with a modest increase in atrial fibrillation in some cardiovascular trials.

Pure Omega contains fish and fish-derived gelatin and is not appropriate for a vegetarian or vegan diet.

The HormoneSynergy® Perspective

MaxSimil® addresses a genuine limitation of conventional fish oil: the digestive work required to absorb different omega-3 forms. Human pharmacokinetic research supports greater short-term absorption of its monoglyceride-rich formulation, especially with a low-fat meal.

That advantage should be described for what it is. MaxSimil® may improve the delivery of EPA and DHA, but it has not been shown to multiply their clinical benefits or turn fish oil into a stand-alone longevity treatment.

RetzlerRx® Pure Omega brings together an absorbable formulation, independent quality testing and an enteric-coated capsule. It is a practical option when supplemental EPA and DHA fit the person’s diet, laboratory findings and health goals.*

For more on how lipids are interpreted within preventive medicine, read Triglyceride-to-HDL Ratio and Insulin Resistance and Remnant Cholesterol: The Overlooked Lipid Marker.

Frequently Asked Questions

What is MaxSimil®?

MaxSimil® is a monoglyceride-rich fish oil technology designed to reduce the digestive processing required before EPA and DHA can be absorbed.*

Has MaxSimil® been studied in humans?

Yes. A randomized crossover pharmacokinetic study found greater short-term EPA and DHA blood exposure from a MaxSimil® monoglyceride formulation than from the triglyceride and ethyl ester formulations tested. The study evaluated absorption, not long-term health outcomes.

Does greater absorption mean three times greater health benefits?

No. Greater blood exposure after a dose does not establish three times greater cardiovascular, cognitive or anti-inflammatory benefit.

How much EPA and DHA are in Pure Omega 650 EC?

One softgel provides 300 mg of EPA and 130 mg of DHA, for 430 mg combined.

What is the difference between Pure Omega 650 EC and Pure Omega 1300 EC?

Pure Omega 650 EC is the smaller foundational formula. Pure Omega 1300 EC is the higher-concentration option and is available in 60- and 120-count bottles. The appropriate product and dose depend on the person’s diet, laboratory findings and clinical goals.

Can Pure Omega replace prescription fish oil?

No. RetzlerRx® Pure Omega is a dietary supplement and is not represented as equivalent to prescription omega-3 therapy. Do not stop or replace prescribed treatment without speaking with the prescribing clinician.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.